CTL Medical received FDA 510(k) clearance to market the MATISSE™ Titanium Anterior Cervical Interbody Fusion cage for use with supplemental fixation, such as the company’s VAN GOGH™ anterior cervical plate.
MATISSE features CTL’s proprietary TiCro™ surface technology, which is designed to offer 200% greater endplate contact surface area. The first version of MATISSE received its clearance in 2012 under AccelSPINE, which was acquired by CTL in 1Q16.
CTL Medical received FDA 510(k) clearance to market the MATISSE™ Titanium Anterior Cervical Interbody Fusion cage for use with supplemental fixation, such as the company's VAN GOGH™ anterior cervical plate.
MATISSE features CTL's proprietary TiCro™ surface technology, which is designed to offer 200% greater endplate contact...
CTL Medical received FDA 510(k) clearance to market the MATISSE™ Titanium Anterior Cervical Interbody Fusion cage for use with supplemental fixation, such as the company’s VAN GOGH™ anterior cervical plate.
MATISSE features CTL’s proprietary TiCro™ surface technology, which is designed to offer 200% greater endplate contact surface area. The first version of MATISSE received its clearance in 2012 under AccelSPINE, which was acquired by CTL in 1Q16.
Copy to clipboard 
